Welcome back to our blog series on National Member News!

We are excited about getting our National Member news out to the world, so more people can find out what it is happening in each country and each member organisation! We caught up with Viola Zajk from Lupus Poland, who talked to us about the incredible work the organisation is doing, the needs of lupus patients in Poland and much more!

Portrait of Viola Zajk with a neutral expression, wearing a beige sweater and a black top.

 

How do you keep in touch with or have contact with your members?

 

In addressing how we stay connected with our members, we emphasise the use of digital media, particularly Facebook (https://www.facebook.com/lupuspoland/) as a primary communication channel. We are also reachable via email and phone, providing personal responses to members’ questions. Recognising the need to evolve, we are also working on launching a newsletter and improving our website to share the latest news and developments with the world.

 

Additionally, we have ventured into audio media with the creation of ‘Radio Reuma’ on Spotify. This podcast, available in Polish, currently features episodes on lupus, including on diagnosis and psychological support, and has also attracted interest from medical professionals. We plan to expand the podcast with more episodes, making it even more accessible to a wider audience.

 

In terms of healthcare initiatives, we worked hard for some time to advocate for a programme for biological treatment; this was successful with the rollout starting in October, enhancing medication accessibility for patients. We are also part of developing a comprehensive care programme for newly diagnosed patients with various forms of inflammatory arthritis, including lupus, to be piloted in 15 locations across Poland. This programme aims to offer coordinated care with multiple specialists in one place, starting in January for newly diagnosed patients. This is a significant step towards centralised and efficient, multi-disciplinary healthcare for lupus patients in Poland.

 

Did you have any special meetings or webinars during the past year (World Lupus Day, Rare Disease Day, Annual General Meeting etc)?

 

We have been actively developing educational webinars, primarily focused on lupus. We have also launched “Surrounded by Care” (https://3majmysierazem.pl/edukacja/otoczeni-wspraciem/ ), a new educational and informational campaign for lupus.

These webinars may not yet be featured on our Lupus Poland page, but they are available on our main website, specifically for the needs of lupus patients. Our efforts are continued to expand these resources with even more podcasts and an upcoming webinar which we hope will take place in December with the help of a renowned rheumatologist in Poland. This collaboration reflects our strong commitment to providing valuable information and support to our community.

 

Our team of wonderful volunteers is key to our efforts. We are currently seeking additional volunteers to help us manage our expanding range of activities and initiatives. There’s a lot to do, and we’re excited about the positive impact we can make, especially as we look towards 2025 when Poland will assume the EU Presidency. Our preparation is already in full swing, with plans to bring extensive information about rheumatology needs to the forefront. This is particularly important, as we have observed an increase in autoimmune disease diagnoses. Our goal is to enhance support for autoimmune diseases across Europe, building on the ideas and momentum generated pre-Covid for better support of people with rheumatological conditions.

 

Has Digital Health improved or changed in your country?

 

It’s clear that we are witnessing significant advancements. We now have the ability to make appointments online, access our medical records, consult with doctors virtually, and these capabilities are continuously improving. A great development is our shift towards digital platforms that can handle prescriptions and referrals, mostly eliminating the need for paper-based processes.

 

One key initiative we are working on is the development of a comprehensive digital platform. This platform already exists and facilitates actions like signing up for COVID vaccinations, whereby patients automatically receive a vaccine invitation and can then select the date and time and their preferred vaccination site. Our aim is to expand this functionality to include all types of medical referrals, improving the ease with which patients can find and schedule appointments with doctors near them.

 

We also appreciate not having to physically visit a doctor for certain needs, like prescription renewals. The ability to handle these matters with a phone call represents a more efficient and patient-friendly approach. This digital health transformation is an ongoing process in our country, with improvements being made every month!

 

What would you most need as support in your country for lupus?

 

We have a strong hope in a new programme designed to provide comprehensive, coordinated care for lupus patients. This programme aims to offer a centralised location where patients can access all the support they need, through a multi-disciplinary team.

 

Additionally, we are focusing on developing platforms that provide essential information on living with lupus, including self-care. Part of this initiative is, of course, the Polish version of the Lupus100 project, which is set to launch in the next few months.

 

This project will offer valuable information on topics patients frequently wonder about: such as how a person can prepare for their first doctor’s visit, what information and documents to bring, and other practical concerns. There is also a need for education around basic healthcare procedures, like urine sample collection. I am reminded in mentioning this of a past awareness campaign featuring Toni Braxton, which used graphics to illustrate the correct method of collecting a urine sample for a whole day. This is a task many patients tell us they find challenging and are often hesitant to ask about. Realising the potential impact of such simple yet crucial information, we believe that educating patients, especially the newly diagnosed on many different aspects of the disease and its treatments, is vital.

  

We emphasise the importance of patient education, starting from the basics and gradually building up to more complex information. This approach is essential not only for supporting people who have had lupus for many years, but for guiding newly diagnosed patients who are just beginning their journey with lupus. Our goal is to improve things so no newly diagnosed patient will face the same challenges and uncertainties that many of us experienced at the start of our lupus journey. Part of that means ensuring people have the necessary knowledge and support right from the beginning.

 

We also aim to develop education around new treatments for all lupus patients. We have therefore expanded our own knowledge and become Clinical Trial Ambassadors. This allows us to better educate others around clinical trials and how to find the right one.

 

Is there anything you think Lupus Europe could help your organisation with?  

 

Yes! The exchange of information and new ideas among patient organisations across Europe is so important. By sharing successful strategies and programmes like those we have established in Poland with organisations in other countries or with other countries where there are no organisations yes, we can collectively enhance patient support. When an approach or resource proves effective for people in one country, that can encourage others to adopt and adapt these initiatives to fit their needs within their own countries. This collaborative effort can significantly contribute to the improvement of lupus care and support throughout Europe.

 

Is there any topic/theme/area that you think Lupus Europe should focus on, on something where European collaboration would make sense?

 

The topic of cross-border healthcare within Europe is definitely an area that needs attention and collaboration. The challenge faced by rheuma patients generally and lupus patients specifically, when moving countries can be significant. There is a lack of guidance on navigating healthcare systems in a new country, especially when it comes to transferring medical prescriptions and understanding different healthcare rules. This issue is not just relevant for young people who might move for their studies, but it also affects those who may travel for leisure or relocate for work within Europe.

 

Dealing with healthcare across European borders can be complex and daunting. A key point of focus should be providing patients with essential information on what they need to know, where to go, and what documents they need to have in the context of different health systems across countries. At the moment each country presents its own unique set of challenges and procedures; a need for streamlined healthcare experiences is evident.

 

This situation underscores the importance of Lupus Europe possibly looking into how cross-border healthcare in Europe could be simplified and what changes might need to be made to ease the burden on patients navigating these complexities. Addressing this issue could significantly improve the quality of life for those who need to access healthcare services in different European countries.

 

Are you aware of the Lupus Europe Member Capacity Building Programme?

 

No, but now aware!

 

Could you tell us a bit about a dream you have as a group?

 

Yes! Our dream is rooted in the hope that advanced therapies, like CAR-T cell therapy, could become accessible to all eligible patients. Specifically, we dream that CAR-T cell therapy, which is currently expensive and still undergoing clinical trials but has shown promising results, will be available for every lupus patient who can benefit from it.

 

 

 

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

💜 We've taken part in the EULAR PARE Conference 2026 in Brussels! And what an interesting opportunity to discuss the future of AI in healthcare!

🌍 Bringing together more than 100 delegates and speakers from across Europe and beyond, the conference explored some of the most important questions surrounding artificial intelligence in rheumatology and patient advocacy.

From the opportunities and risks of AI to health inequalities, accessibility and European health policy, the discussions highlighted why patient perspectives must be part of the conversation.

🤩 We were particularly proud to see Jeanette Andersen, Chair of the Lupus Europe Board, sharing our experience with #LupusGPT in her presentation, “AI as a Partner in Care: Empowering the RMD Community with Information”.

💡 Jeanette explained how #LupusGPT was developed with patients and clinicians to offer free, multilingual access to reliable lupus information based on validated sources.

She also introduced #EasyLupus, which provides the same trusted information in simpler language, highlighting why accessibility must be considered when developing AI tools.

But one of the most important messages from her presentation went beyond technology.

💜 Patient organisations have much more to contribute to AI than simply using tools developed by others.

As Jeanette highlighted, patient organisations bring lived experience, knowledge of unmet needs, trusted information and an understanding of the barriers people face when accessing health information.

Technology alone cannot tell us what patients really need or what makes a tool genuinely useful.

Patients and patient organisations should not simply be users of AI. They should help shape its development.

👏 A big thank you to EULAR PARE for bringing together so many different perspectives and creating space for meaningful discussions about the future of healthcare and patient involvement!
...

💜 Weve taken part

🦋 One of the greatest strengths of patient organisations is the support, understanding and sense of community they offer to people living with lupus. 💜

🇧🇬 A great example comes from Организация на пациентите с ревматологични заболявания, who shared their psychological support initiative at the #LupusConvention!

💜 Launched in December 2025, this pilot project provides a safe and supportive space where participants can share their experiences and discuss the challenges of living with lupus, from fatigue and anxiety to relationships and everyday life.

👥 Led by a clinical psychologist, the group currently brings together six women. The project is expected to run until December 2026, while the organisation explores funding opportunities to continue and expand the initiative.

Thank you to our Bulgarian colleagues for sharing their experience, and congratulations on the amazing job you are doing! ❤️

🌍 This is just one example of the valuable work patient organisations are doing across Europe, often responding to needs that go beyond medical care. We'll share more in the coming days!

💜 Are you living with lupus? You don't have to navigate everything alone! Your national lupus organisation may offer information, support, activities and opportunities to connect with others who understand your experiences.

🔗 Find your national lupus organisation and get in touch:
lupus-europe.org/lupus-members/
...

Image attachment
Image attachment

💜 Young people living with lupus are not only the future of patient advocacy. Their voices matter today!

On 23 and 24 October, LUPUS EUROPE was delighted to be represented at the first 𝗘𝗣𝗙 𝗬𝗼𝘂𝘁𝗵 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝟮𝟬𝟮𝟲 in Brussels by Ana Rita Vieira, from the LUPUS EUROPE Youth Group, and Lena Koskina, LUPUS EUROPE's Youth Group Coordinator.

🌍 Organised by European Patients' Forum and its EPF Youth Group, the Congress brought together young patient advocates from across Europe to explore the challenges facing young people living with chronic conditions, from economic uncertainty and climate change to the barriers they encounter when trying to influence healthcare decisions.

🌟 One particularly important question ran through the discussions: 𝗵𝗼𝘄 𝗱𝗼 𝘄𝗲 𝗺𝗼𝘃𝗲 𝗯𝗲𝘆𝗼𝗻𝗱 𝘀𝗶𝗺𝗽𝗹𝘆 𝗴𝗶𝘃𝗶𝗻𝗴 𝘆𝗼𝘂𝗻𝗴 𝗽𝗲𝗼𝗽𝗹𝗲 𝗮 𝘀𝗲𝗮𝘁 𝗮𝘁 𝘁𝗵𝗲 𝘁𝗮𝗯𝗹𝗲, 𝗮𝗻𝗱 𝗲𝗻𝘀𝘂𝗿𝗲 𝘁𝗵𝗲𝘆 𝗵𝗮𝘃𝗲 𝗮 𝗿𝗲𝗮𝗹 𝘀𝗮𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝗯𝗲𝗶𝗻𝗴 𝗺𝗮𝗱𝗲❓

The conversations also highlighted something easily overlooked: 𝗺𝗲𝗮𝗻𝗶𝗻𝗴𝗳𝘂𝗹 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝘀 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝗮𝗻 𝗶𝗻𝘃𝗶𝘁𝗮𝘁𝗶𝗼𝗻. Young people living with chronic conditions are often balancing their health with education, employment and financial pressures. Advocacy opportunities need to recognise those realities, and not be accessible only to those who can afford the time and resources to participate.

🦋 At LUPUS EUROPE, supporting the Youth Group means actively helping create those opportunities, connecting young advocates with others across Europe and ensuring their perspectives can meaningfully contribute to the work we do.

Young people living with lupus are already advocates, bringing their experiences, ideas and knowledge into conversations that matter.

💜 Thank you to European Patients' Forum and its EPF Youth Group for bringing everyone together, and to Rita and Lena for representing LUPUS EUROPE at this important Congress!
...

💜 Young people li

🔊 Hot off the press!

💜 Treatment adherence is important, complex and multifactorial.

But understanding the importance of treatment adherence is not the same as knowing how to support it in everyday clinical practice.

That’s why, in 2020, EULAR published its Points to Consider for the prevention, screening, assessment and management of nonadherence to treatment in people with rheumatic and musculoskeletal diseases.

But having recommendations is only the first step. How can we ensure they become part of everyday clinical practice?

🤩 An interesting new viewpoint published in EULAR Rheumatology Open, co-authored by Jeanette Andersen, Chair of the Lupus Europe Board, now explores the challenges of putting these recommendations into routine rheumatology care.

The article highlights that nonadherence is not simply a matter of individual patient behaviour. Concerns about treatment, practical difficulties, access to medication, socioeconomic circumstances and communication with healthcare professionals can all play a role.

The authors highlight five key priorities for putting adherence support into routine rheumatology practice:

🔹 Assessment: Identifying adherence behaviours and the barriers behind them.
🔹 Monitoring: Reassessing adherence over time, as it may change throughout the disease course.
🔹 Shared decision-making: Discussing patients’ preferences, expectations and concerns through non-judgemental communication.
🔹 Multidisciplinary care: Involving the wider healthcare team according to individual needs.
🔹 Training: Making adherence support part of rheumatology education and professional development.

💜 The challenge is not the lack of recommendations, but making adherence assessment and support a routine part of rheumatology care.

📖 Read the open-access viewpoint: doi.org/10.1016/j.ero.2026.100261
...

Image attachment
Image attachment
Image attachment
Image attachment
LUPUS EUROPE Uniting people with Lupus throughout Europe
Send